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SMO (Smoothened), the central transducer of Hedgehog sig-
naling, is coupled to heterotrimeric Gi proteins in many cell
types, including cardiomyocytes. In this study, we report that
activation of SMO with SHH (Sonic Hedgehog) or a small ago-
nist, purmorphamine, rapidly causes a prolongation of the
action potential duration that is sensitive to a SMO inhibitor. In
contrast, neither of the SMO agonists prolonged the action
potential in cardiomyocytes from transgenic GiCT/TTA mice,
in which Gi signaling is impaired, suggesting that the effect of
SMO ismediatedbyGiproteins. Investigationof themechanism
underlying the change in action potential kinetics revealed that
activation of SMOselectively reduces outward voltage-gatedK
repolarizing (Kv) currents in isolated cardiomyocytes and that it
induces a down-regulation of membrane levels of Kv4.3 in car-
diomyocytes and intact hearts from WT but not from GiCT/
TTAmice.Moreover, perfusion of intact heartswith Shhor pur-
morphamine increased the ventricular repolarization time (QT
interval) and induced ventricular arrhythmias. Our data consti-
tute the first report that acute, noncanonicalHh signalingmedi-
ated by Gi proteins regulates K
 currents density in cardiomyo-
cytes and sensitizes the heart to the development of ventricular
arrhythmias.
The vertebrate Hh (Hedgehog) pathway is initiated by bind-
ing of SHH (Sonic Hedgehog), Indian Hedgehog, or Desert
Hedgehog to Patched1 (1). Ligand binding inhibits Patched1,
leading to derepression of the central transducer protein SMO
(Smoothened), a member of the G protein–coupled receptor
(GPCR)2 superfamily (1). Activation of SMO facilitates conver-
sion of theGli family of transcriptional regulators into full tran-
scriptional activators. Conversely, in the absence of Hh ligands,
GLI2 andGLI3 are processed into transcriptional repressors by
cAMP-dependent kinase (PKA), glycogen synthase kinase 3,
and casein kinase I phosphorylation ofmultiple residues, which
targets them for partial proteasomal degradation (1–4). SMO
has an evolutionarily conserved function to selectively activate
the Gi family of heterotrimeric G proteins (5–7). Activation of
Gi proteins reduces the intracellular levels of cAMP and the
activity of PKA, the main negative regulator of the GLI2 and
GLI3 transcription factors. However, the requirement of Gi for
activation of the GLI transcription factors is cell type- and
context-dependent. This is not surprising because PKA activity
is determined by the net activity of a plethora of GPCRs that
stimulate or inhibit adenylyl cyclase, their localization, the
presence of agonists, and the expression profile of PKA-regula-
tory proteins. Notwithstanding the role of Gi in GLI activation,
the function of SMO as a GPCR is essential for several nonca-
nonical Hh signaling outputs and, as opposed to the canonical
pathway, is rapid and independent ofGLI-transcriptional activ-
ity (8–11).
GLI-dependent and -independent Hh signaling coexist in
cells that have primary cilia, mainly cells in interphase or qui-
escent, like cardiomyocytes. We previously reported that
SMO/Gi protein coupling mediates up-regulation of canonical
Hh signaling in response to ischemia and reperfusion injury,
using animals with Tet-Off controlled cardiomyocyte-specific
expression of a Gi inhibitory peptide (the C-terminal domain of
the Gi2 subunit) (GiCT/TTA mice) (12, 13). In addition, we
found that SMO activation rapidly reduces cAMP levels ele-
vated in response to 2-adrenergic receptor stimulation with
isoproterenol (ISO) in cardiomyocytes in a Gi protein–depen-
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dent manner (12). Because Gi proteins regulate a large number
of ionic channels that shape the action potential through inhi-
bition of adenylyl cyclase/PKA by Gi subunits, our previous
findings suggested that noncanonical Hh signaling could have
important repercussions in cardiac physiology.
In this study, we sought to investigate whether SMO/Gi cou-
pling could regulate cardiac electrophysiology. Our results
demonstrate that SMO/Gi coupling selectively reduces out-
ward repolarizing K currents mediated by Kv channels,
increases the action potential (AP) duration and induces ven-
tricular arrhythmias.
Results
Hedgehog signaling increases cardiomyocyte action potential
duration in a Gi-dependent manner
We first evaluated whether activation of SMO with Shh or
with a small molecule agonist, purmorphamine (PUR) (14),
resulted in acute changes of AP parameters. We recorded APs
on ventricular cardiomyocytes isolated from adult WT mice
using the whole-cell configuration of the patch-clamp tech-
nique. We found that addition of Shh or PUR to cardiomyo-
cytes caused a rapid onset (5 min) prolongation of the AP
Figure 1. Activation of Smoothened prolongs the action potential duration in isolated mouse ventricular cardiomyocytes. A, representative
examples of APs measured from WT myocytes at 1 Hz after 5 min of perfusion with 0.1% DMSO (vehicle), 5 M PUR or 2.5 g/ml recombinant Shh. B,
representative phase-plane plots of APs individual cardiomyocytes treated as in A. C, APD to reduce the maximal amplitude by 25% (APD25), 50%
(APD50), 75% (APD75), or 90% (APD90) in cardiomyocytes stimulated for 5 min as in A. One-way ANOVA was used. *, p  0.05; **, p  0.01 (n  4 – 6
cardiomyocytes from independent isolation). D, length of the APD90 in cardiomyocytes pretreated or not for 2 h with 0.5 M KAAD-CP, followed by 5 min
of stimulation with 0.1% DMSO (vehicle), 5 M PUR, or 2.5 g/ml rShh (Shh). One-way ANOVA was used. *, p  0.001; **, p  0.05 (n  5– 6 cardiomyo-
cytes from independent isolations). E, representative examples of APs measured from TTA and GiCT/TTA myocytes at 1 Hz after 5 min of perfusion with
0.1% DMSO (vehicle) or 5 M PUR. F, representative phase-plane plots of APs individual cardiomyocytes from GiCT/TTA mice, treated as in A. All
quantitative data are expressed as means  S.E.
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duration (APD) measured at 1 Hz, compared with vehicle con-
trol (Fig. 1A). No spontaneously triggered activity was observed
in cardiomyocytes stimulated with PUR or Shh. Phase-plane
plot analysis of the traces show that the repolarization speed is
strongly reduced by Shh or PUR (Fig. 1B). A summary of AP
characteristics of vehicle and PUR-treatedWT cardiomyocytes
at a frequency of 1Hz showedno difference in any other param-
eter (Fig. S1). The APD was significantly prolonged by Shh or
PUR throughout the entire repolarization phase (Fig. 1C), and it
was mediated by SMO, because it was prevented by the inverse
agonist KAAD-cyclopamine (Fig. 1D) (5). Remarkably, PUR
failed to elicit a prolongation of the APD in cardiomyocytes
isolated from GiCT/TTAmice (Fig. 1, E and F), indicating that
Gi activation downstreamof SMOmediates APDprolongation.
PUR did not affect the time to achieve 90% repolarization
(APD90), nor any other AP parameter, in GiCT/TTA car-
diomyocytes (DMSO: 26  4 ms versus PUR: 19  7 ms)
(Fig. S2).
Because the repolarization phase is faster in the mouse heart
and lacks the characteristic plateau of human cardiomyocytes,
we also investigated the effect of acute SMO activation with
PUR on ventricular cardiomyocytes isolated from guinea pigs,
which have an AP kinetics similar to human cardiomyocytes.
Consistent with the mouse data, PUR increased repolarization
time in guinea pig cardiomyocytes by 50%, as shown in a
representative trace (Fig. 2A) and in APD measurements (Fig.
2B). These findings demonstrate that activation of SMO/Gi sig-
naling with either Shh or PUR rapidly increases repolarization
time of single cardiomyocytes by a noncanonical signaling
pathway, because the response time is incompatible with Gli-
dependent transcription changes.
Smoothened activation causes a reduction in outward
repolarizing K currents
The repolarization phase of the AP is governed by several
Ca2-, Na-, and K-permeable channels. Among the latter,
voltage-gated K currents are the main determinants of AP
repolarization kinetics (15). Prolongation of the APD can be
caused by an increase in inward rectifying K currents and/or a
reduction of outward K currents (IK).We recordedwhole-cell
Kv currents in ventricular myocytes isolated from WT mice
treated with PUR or DMSO (vehicle).With voltage-gated Ca2
and Na currents blocked, outward IK currents were recorded
during 4.5-s depolarizing voltage steps to potentials between
40 and 40 mV from a holding potential of 70 mV; repre-
sentative outwardK currentwaveforms recorded inWTadult
mouse cardiomyocytes are shown in Fig. 3A. As expected for
this current, the rate of rise and the amplitude increased with
depolarization; the largest and most rapidly activating current
in Fig. 3A was evoked at 40 mV. Thus, the currents analyzed
here were assumed to reflect only the activation of Ca2-inde-
pendent, depolarization-activated Kv channels. These currents
were markedly reduced by PUR (Fig. 3A). Peak outward K
current densities at all tested positive potentials were lower in
PUR-treated cells than in vehicle-treated controls (Fig. 3B),
reaching the maximal difference at 40 mV (PUR  9.9  1.1
pA/pF, n  13 versus DMSO  16.9  1.5 pA/p, n  15).
Conversely, PUR did not modify inward rectifying K currents
(Fig. S3), ruling them out as mediators of the AP remodeling by
SMO/Gi signaling.
The decay phase of the outwardKv currents can be described
by the sum of two exponentials, reflecting the fast components
of inactivation (Ito,f), the slow components of inactivation
(IK,slow), and a noninactivating current (Iss) (16). Fitting and
kinetic analyses of the total Kv currents revealed that Ito,f
and IK,slow densities were reduced in PUR-treated cells by 48
and 29% at 40 mV, respectively (Table 1). The mean whole-
cell membrane capacitance (Cm) was not affected by PUR, indi-
cating that the reduced Ito,f and IK,slow current densities are not
the result of nonspecific cellular enlargement. No significant
differences in the densities of the steady-state outward K cur-
rents, Iss, determined as the currents remaining at the end of
4.5-s voltage steps, were observed.
To further confirm the finding of the fitting analysis, we
performed a two-step voltage inactivation protocol to isolate
Ito,f. Inactivation of the fast component by delivery of a pre-
pulse of30mV revealed a significant decrease in Ito,f of 25%
at 40 mV after incubation with PUR (Fig. 3C). Thus, acute
stimulation of SMO reduces outward K current density in
cardiomyocytes.
In adult mouse ventricular myocytes, Ito,f is mediated Kv4.2/
Kv4.3 pore-forming  subunits and KChiP auxiliary subunits,
whereas IK,slow is mediated by Kv1.4, Kv1.5, and Kv2.1 (15, 16).
Figure 2. Activation of Smoothened prolongs the action potential dura-
tion in guinea pig ventricular cardiomyocytes. A, representative AP elic-
ited in isolated guinea pig ventricular cardiomyocytes incubated with 0.1%
DMSO (black trace) or 5 M purmorphamine (red trace) for 1 h. B, mean APD to
reduce the maximal amplitude by 50% (APD50) and 90% (APD90) in guinea
pig cardiomyocytes treated as in A. The data are expressed as means  S.E.
Student’s t test was used. *, p  0.005; **, p  0.0001 (n  7– 8
cardiomyocytes).
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To test the idea that Ito,f remodeling by SMO is mediated by
altered distribution of Kv channels, we immunostained several
Kv channel subunits on isolated ventricular myocytes treated
with vehicle or PUR for 15min.Mean fluorescence signal inten-
sity of Kv4.3 at or near the cell surface quantified on confocal
Z-scan images was 79% lower in PUR-treated cells (35  9,
n  8) compared with vehicle control (165  34, n  8) (Fig.
4A). Remarkably, no difference in Kv4.3 staining was observed
in cardiomyocytes from GiCT/TTA mice (vehicle: 97.3  14.0
versus PUR: 131.6  8.9, n  8) (Fig. 4A). Thus, immunofluo-
rescence experiments yielded data consistent with the whole-
cell patch-clamping results. In contrast, Kv4.2, Kv2.1, Kv1.5,
Kv1.4, Kir2.1, and Kir2.2 staining was not affected by PUR (Fig.
S4). Next, we perfused hearts from TTA or GiCT/TTA mice
with vehicle, PUR, or PUR after 30 min of perfusion with
KAAD-cyclopamine. Upon perfusion, we prepared left ventri-
cle homogenates and separated the membrane and soluble
fractions. Western blotting analysis revealed a specific 40%
Figure 3. Outward repolarizing K currents in ventricular myocytes are reduced after SMO activation. A, representative whole-cell Kv currents recorded
at room temperature from vehicle control (DMSO) and 5 M PUR-treated ventricular myocytes in response to 4.5-s depolarizing voltage steps to test potentials
between 40 and 40 mV (10-mV increments) from a holding potential of 70 mV. Recorded currents were normalized for differences in cell size (whole-cell
membrane capacitance) to obtain current densities. B, peak outward K current densities as a function of voltage in vehicle-treated versus purmorphamine-
treated cardiomyocytes (means  S.E., n  11–12 cardiomyocytes). C, depolarization-induced Kv inactivation to investigate the contribution of Ito,f to the total
outward IK currents. Panel a, whole-cell Kv currents were recorded in response to voltage steps to potentials ranging from 40 to 40 mV (in 10-mV
increments) from a holding potential of 70 mV in vehicle control (DMSO) or 5 M PUR-treated cardiomyocytes. Panel b, outward Kv currents evoked at the
same test potentials following a brief prepulse to 20 mV from a holding potential of 30 mV to inactivate Ito,f. Panel a– b, the amplitudes of Ito,f in individual
cells of each group were then obtained by digital off-line subtraction of the recordings with the prepulse (panel b) from the recordings without the prepulse
(panel a).
Table 1
Modulation of outward K current in isolated cardiomyocytes from wildtype mice stimulated with purmorphamine
The results were determined by Student’s t test and indicate the number of cardiomyocytes tested in each condition, isolated from seven different hearts.
Density
Treatment IK,slow Ito,f Iss k,slow to,f Ito,f/IK,total
pA/pF pA/pF pA/pF ms ms
DMSO (n  15) 9.7  0.8 4.2  0.7 4.1  0.4 1455  152 113  9 0.22  0.1
PUR (n  13) 6.9  0.8a 2.2  0.4a 5.1  0.8 1507  177a 93  8a 0.16  0.1a
a p  0.05, PUR versus DMSO.
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reduction of Kv4.3 by PUR in themembrane fraction of control
hearts, which was prevented by KAAD-cyclopamine, but the
decrease was not evident in hearts from GiCT/TTA mice (Fig.
4B). Altogether, these data suggest that a reduction in plas-
malemmal Kv4.3 levels underlies the decrease in Ito,f density
induced by SMO agonists.
Smoothened reduces PKA activity, increases repolarization
time, and induces arrhythmias in intact hearts in a
Gi-dependent manner
We next evaluated whether SMO activation had global
effects on PKA activity in the intact heart as it does in iso-
lated neonatal cardiomyocytes (12). Hearts from WT mice
were perfused ex vivo using the Langendorff technique for 20
min in Tyrode’s buffer, followed by 10 min with ISO to stim-
ulate Gs-dependent cAMP production and PKA activation.
As a measure of PKA activity, we evaluated phospholamban
phosphorylation at Ser-16 (S16-PLN), a well-characterized
PKA site (17), in whole-tissue homogenates prepared at the
end of perfusion. As expected, ISO increased S16-PLN phos-
phorylation by 4-fold (Fig. 5A). Simultaneous perfusion with
PUR prevented Ser-16 phosphorylation (Fig. 5A). Addition
of KAAD-cyclopamine (KAAD-CP), a SMO inverse agonist,
during the equilibration period, prevented the reduction in
phospho-S16-PLN by PUR (Fig. 5A), indicating that the
effect of PUR is specifically mediated by activation of SMO.
These findings demonstrate that PUR opposes PKA activa-
tion specifically through SMO and, together with the find-
ings in isolated cardiomyocytes, suggested that acute activa-
tion of SMO in the heart could modulate events relevant to
cardiac physiology. In agreement with this hypothesis, per-
fusion of WT mouse hearts with PUR or Shh resulted in a
transient depression of the autonomic heart rate (HR) (Fig.
S5) and increased the HR-corrected QT (QTc) interval,
which reflects the repolarization phase of themyocardial AP,
as determined using volume-conducted electrocardiography
(ECG) (Fig. 5B). To investigate whether this was mediated by
activation of Gi proteins by SMO, we tested the effect of PUR
on hearts from GiCT/TTA mice. This mouse model is supe-
rior to the use of pertussis toxin to inhibit Gi because it
allows the analysis of reduced Gi activity exclusively in car-
diomyocytes, avoids the need to pretreat the animals with
the toxin prior to excision of the heart and the risk of partial
efficacy of Gi ADP-ribosylation, and eliminates the co-
occurrence of stress triggered signals caused by acute Gi
inhibition. Remarkably, although the baseline ex vivo ECG
parameters in hearts from GiCT/TTA mice were compara-
ble with TTA control hearts, with exception of a lower HR (1
S1), perfusion with PUR did not increase the QTc interval in
GiCT/TTA hearts, whereas it did in littermate TTA controls
(Fig. 5C). Prolongation of the QTc interval is strongly asso-
ciated with development of arrhythmias. Thus, we analyzed
the ECG recordings for signs of arrhythmic episodes.
Remarkably, perfusion with SMO agonists in Tyrode’s solu-
tion induced ventricular arrhythmias in hearts from control
mice, but not from GiCT/TTA animals (Fig. 5, D and E, and
Tables 2 and 3). Arrhythmic episodes were never detected in
any genotype perfused with vehicle for up to 1 h (Fig. 5,D and
E). Activation of SMO in control hearts resulted in a very
high incidence of ventricular premature beats (VPBs) (100%
of PUR-perfused and 80% of Shh-perfused) and ventricular
tachycardia (VT) (82% of PUR-perfused and 22% of Shh-
perfused hearts, respectively) (Fig. 5E and Table 2). Perfu-
sion with the SMO inhibitor KAAD-CP before addition of
either Hh agonist greatly reduced the number of VPBs and
completely prevented the occurrence of VT (Fig. 5E and
Table 2). These findings demonstrate that SMO-dependent
activation of Gi induces rapid electrophysiological changes
that are conducive to ventricular arrhythmias.
Figure 4. Down-regulation of Kv4.3 membrane levels by SMO activation is Gi-dependent. A, immunofluorescent staining of Kv4.3 in fixed cardiomyocytes
isolated from TTA or GiCT/TTA mice after 15 min of incubation with 0.1% DMSO or 5 M PUR. B, 20 mg of protein in crude membrane preparations from hearts
of TTA and GiCT/TTA mice, perfused as described with vehicle (DMSO), 5 M PUR, or 0.5 M KAAD-cyclopamine followed by 5 M PUR were separated by
SDS-PAGE and blotted using anti-Kv4.3 antibody. The graph shows densitometric quantification of Kv4.3 levels in ventricle membrane preparations from TTA
mice (black circles) or GiCT/TTA mice (red circles) treated as indicated. Student’s t test was used. *, p  0.05 (n  4 hearts).
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Figure 5. Activation of Smoothened in intact hearts inhibits PKA signaling and induces ventricular arrhythmias in a Gi protein– dependent manner.
A, WT mice hearts were retrogradely perfused for 20 min using the Langendorff technique with 1 M isoproterenol (ISO), 5 M PUR, or 0.5 M KAAD-CP together
with purmorphamine. Tissue homogenates were separated by SDS-PAGE and immunoblotted using anti-Ser(P)-16 phospholambdan (PS16)-PLN and -actin
for loading control. For densitometric quantification of the fractional PS16-PNL, the data represent means  S.E. Students’ t test was used. *, p  0.05 (n  3).
B, length of the QT interval corrected by heart rate (QTc) in WT mice hearts perfused with 0.1% DMSO (black circles), 5 M purmorphamine (red circles), 20%
DMEM (vehicle, open black circles), or Shh in 20% DMEM (Shh, open red circles) for 20 min. The data represent means  S.E. One-way ANOVA was used. *, p  0.05,
PUR versus DMSO (n  8); **, p  0.001, Shh versus vehicle (n  5). C, effect of perfusion with 0.1% DMSO (black circles) or 5 M purmorphamine (red circles) on
QTc interval prolongation in control mice (TTA) versus transgenic GiCT/TTA mice. One-way ANOVA was used. *, p  0.01 (n  4 – 8). D, representative ECG traces
in WT mice hearts perfused with 0.1% DMSO or with 5 M PUR. Arrows indicate examples of VPB and VT. E, incidence of VPBs and VTs in hearts from control TTA
mice or from GiCT/TTA animals during 20 min of perfusion with vehicle (combined data from 0.1% DMSO and 20% DMEM), 5 M PUR, Shh in 20% DMEM (Shh),
or the latter with inclusion of 0.5 M KAAD-CP during the equilibration phase (n  5– 8). The numbers inside the pie charts indicate the percentages of hearts
with said type of arrhythmia.
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Since our initial report of coupling of SMO toGi proteins (5),
mounting evidence suggested that although it contributes to
Gli activation in some cell types but not all (10, 18), the most
important function of SMO/Gi coupling is in acute noncanoni-
cal signaling events. This study shows the physiological rele-
vance of SMO-Gi coupling in mediating a novel acute effect of
Hh signaling in the myocardium. First, we show that activation
of Gi by SMO in the myocardium is strong enough to oppose
PKAactivation by adrenergic stimulation, because of a decrease
of cAMP production in single cardiomyocytes (reported in our
previous study (12)). We observed a rapid-onset prolongation
of the AP duration in isolated cardiomyocytes by stimulation of
the Hh pathway with Shh or the small molecule agonist PUR,
which was completely prevented by impairment of Gi signaling
in cells from GiCT/TTA mice and was specifically reduced by
a SMO inhibitor. SMO/Gi coupling was also required for
increased turnover of Kv4.3 pore-forming subunits of Kv chan-
nels, which underlies a decrease in total and fast outward repo-
larizing K currents and provides an explanation for the pro-
longation of the AP. Remarkably, the same effect is observed in
theAPof guinea pig cardiomyocytes, which have anAP kinetics
and channel function more similar to human myocardial cells.
An important consequence of the acute effect ofHh signaling
on the AP of individual cardiomyocytes is the high incidence of
ventricular arrhythmias, which require active Gi signaling. Col-
lectively, our findings demonstrate the existence of a nonca-
nonical Hh pathway in the myocardium that could trigger dan-
gerous arrhythmias. Therefore, the proposed development of
small molecule agonists of the Hh pathway for therapeutic use
after ischemic cardiac events, mostly to improve revasculariza-
tion (19), should be carefully reconsidered in the light of our
findings, because the beneficial proangiogenic effects of Shh
could be attained by other growth factors that do not trigger
electrophysiological changes.
Future studies will be necessary to investigate whether the
effect of Hh on myocardial function changes over time as the
effect of parallel signaling outputs kicks into effect, such as
reduction of caspase activity and induction of GLI transcrip-
tional targets. In this regard, during the completion of our
studies, an article was published that concludes that Shh
reduces AP duration based on evaluation of the effect of Shh
after 6 h (20). A potential explanation for the contradictory
findings is that desensitization of noncanonical SMO/Gi sig-
naling after the rapid onset effects could result in a late dis-
tinct remodeling phenotype or, as mentioned above, other
effectors of the Hh signaling pathway that are activated with
a slower kinetics could have a different effect on the AP
kinetics. Electrophysiological evaluation of healthy adult
cardiomyocytes at longer times postisolation was not possi-
ble because of a decrease in cell viability, and the use of
neonatal cardiomyocytes for longer term experiments is dis-
couraged because they express a different set of ionic chan-
nels. Nevertheless, our exhaustive analysis using the physio-
logical agonist Shh and an agonist and an antagonist of SMO
prove the connection between SMO signaling and acute
changes in repolarization kinetics. Moreover, the fact that
cells from GiCT/TTA mice are refractory to the SMO ago-
nists also serves as a control of specificity of the agonists
used, which do not appear to have nonspecific effects on the
ionic channels that govern the AP phases.
Our data point at Kv4.3 and/Kv4.2 channels, the molecular
determinants of Ito,f, as targets of acute SMO signaling. Phos-
phorylation of Kv channels by PKA, protein kinase C (PKC),
and calmodulin-dependent protein kinase II (CAMKII) kinases
regulates their gating properties and their membrane localiza-
tion (21, 22), and both PKA and PKC are known to be engaged
by SMO (23). Nevertheless, because of the central role of Gi
proteins as strict mediators of SMO in the heart and the pleio-
tropic effect of PKA signaling in the regulation of the cardiac
AP, we believe that changes in other ionic currents, beyond
those analyzed in this study, might also contribute to the repo-
larization phenotype. In conclusion, we report for the first time
a regulatory effect of acute, noncanonical cardiac Hh signaling
in the rodent heart that results in remodeling of Kv channels
and an increased incidence of arrhythmias. Given the up-regu-
lation of Shh in response to hypoxia, it will be relevant to inves-
tigate in the future a potential link between theHh pathway and
the occurrences of life-threatening arrhythmias in patients sur-
viving myocardial infarction.
Table 2
Incidence and characteristics of arrhythmias in hearts from adult TTA mice in response to acute perfusion with Hedgehog agonists
Hearts from 3–5-month-old TTAmice were perfused in Tyrode’s buffer for 20 min followed by addition of vehicle (DMSO or 20% DMEM (vehicle)) or the agonists PUR
or Shh for another 20 min or were perfused with Tyrode’s buffer containing KAAD-CP for 20 min followed by perfusion for another 20 min with KAAD-CP plus PUR or
KAAD-CP plus Shh.
Parameter DMSO (n  6) PUR (n  8) KAAD-CP  PUR (n  8) Vehicle (n  5) Shh (n  5) KAAD-CP Shh (n  5)
VPB (events/20 min) 0 268a 9b 0 46a 8b
VPB incidence (% hearts) 0 100a 37.5b 0 80a 40b
VT (events/20 min) 0 184a 0b 0 1a 0
VT incidence (% hearts) 0 87.5a 0b 0 20a 0
Mean VT duration (ms) 0 1,020  670a 0b 0 740 0
ap  0.05, PUR versus DMSO and Shh versus vehicle.
b p  0.05, PUR versus KAAD-CP  PUR and Shh versus KAAD-CP  Shh.
Table 3
Incidence and characteristics of arrhythmias in hearts from adult GiCT/
TTA mice in response to acute perfusion with Hedgehog agonists
Hearts from 3–5-month-old GiCT/TTAmice were perfused in Tyrode’s buffer for
20 min followed by addition of vehicle (DMSO or 20% DMEM (vehicle)) or by PUR










VPB (events/20 min) 0 0 0 1
VPB incidence (% hearts) 0 0 0 16.7
VT (events/20 min) 0 0 0 0
VT incidence (% hearts) 0 0 0 0
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The mice were housed, handled, and euthanized according
to the National Institutes of Health Guide for the Care and Use
of Laboratory Animals. All procedures were approved by the
Thomas Jefferson University Committee on Animal Care
(Institutional Animal Care and Use Committee protocol no.
831D). GiCT/TTA mice, their TTA littermates, and WT mice
were used for the study. Transgenic cardiomyocyte-specific
inducible GiCT mice (GiCT/TTA) were obtained by breeding
mice encoding a doxycycline-sensitive TTA transgene (-my-
osin heavy chain (MHC)–TTA) with mice encoding a TTA-
driven -MHC–GiCT transgene, as previously described (13).
GiCT/TTA animals showed normal size, appearance, and sur-
vival when compared with WT littermates as reported previ-
ously (13). No sudden death was observed in either WT or
GiCT/TTA mice (age  5 months). Hearts from GiCT/TTA
animals were also normal in appearance and weight. Electro-
physiological analysis using volumetric ECG recordings indi-
cated ECG baseline parameters in GiCT/TTA mice were simi-
lar to WT littermates. None of the transgenic animals showed
any overt phenotype under nonstress conditions, but GiCT/
TTAmice did have a reduced recovery of cardiac function after
ischemia/reperfusion injury, as previously published. Guinea
pigs (DunkinHartley, 300–350 g)were purchased fromCharles
River (Kent, UK) and housed at the University of Leeds follow-
ing approved institutional guidelines.
Isolation of adult mouse cardiomyocytes
Adult WT and GiCT/TTA mice were anesthetized with tri-
bromoethanol (Avertin; 100 mg/kg, intraperitoneally; Sigma),
anticoagulated with heparin sodium (0.5 unit/g, intraperitone-
ally). The hearts were surgically removed via a thoracotomy.
Although fully immersed inCa2 free Tyrode’s (135mmol/liter
NaCl, 4 mmol/liter KCl, 0.33 mmol/liter NaH2PO4, 1 mmol/
liter MgCl2, 10 mmol/liter HEPES, 10 mmol/liter glucose, and
10 mmol/liter 2,3-butanedione monoxime), the aorta was can-
nulated and mounted on a Langendorff apparatus. Following a
10–12-min enzymatic digestion with 0.5 mg/ml collagenases B
and D (Roche) and 0.02 mg/ml protease XIV (Sigma), the heart
was submersed in Ca2 free Tyrode’s, whereas the atria and
aorta were removed. The myocytes were then extracted from
the heart in Ca2-free Tyrode’s with BSA. Isolated myocytes
were resuspended in 4% fetal bovine serum minimum Eagle’s
medium (Sigma), plated on laminin-coated coverslips, and
placed in a 95% air, 5% CO2 incubator at 37 °C. Approximately
1 h after plating, Ca2-tolerant ventricular myocytes adhered
to the laminin, and damaged cells were removed by replacing
the medium with fresh serum-free minimum Eagle’s medium,
supplemented with antibiotics (penicillin/streptomycin). The
cells were examined electrophysiologically within 6 h of
isolation.
Isolation of guinea pig myocytes
Guinea pig ventricular myocytes were isolated according to
methods described in detail elsewhere (24). The use of guinea
pigs was approved by the UK Home Office. The guineas pigs
(Dunkin Hartley, 300–350 g) were euthanized by cervical dis-
location following the UKHomeOffice Guidance on the Oper-
ation of Animals (Scientific Procedures) Act 1986 and Univer-
sity of Leeds institutional guidelines. Cervical dislocation was
performed by a highly skilled operator, followed by quick tho-
racotomy to remove the hearts, which were then perfused for 5
min at 37 °C as a Langendorff preparation, with a Ca2-free,
oxygenated isolation solution containing 135 mmol/liter NaCl,
6 mmol/liter KCl, 0.33 mmol/liter NaH2PO4, 5 mmol/liter
sodium pyruvate, 1 mmol/liter MgCl2, 10 mmol/liter HEPES,
and 10 mmol/liter glucose (adjusted with NaOH) with colla-
genase type II (Worthington, LORNE; 100 units/ml) protease
(Sigma; 0.66 mg/ml) and BSA (Sigma; 1.66 mg/ml) for 5 min
and then washed with 1 mmol/liter Ca2-containing isolation
solution for an extra 5 min. The ventricles were cut free and
minced in fresh isolation solution with 1mmol/liter CaCl2, and
myocytes were isolated and stored at room temperature for up
to 6 h after isolation.
Hedgehog pathway agonists and antagonists
Experiments using isolated cardiomyocytes were performed
using recombinant Shh, purified as previously described (25).
Experiments of intact heart perfusion, because of the large
amount of perfusion medium needed, were performed using
Shh-containing or control-conditioned medium prepared as
follows. HEK 293 (CRL-1573) cells were obtained from Amer-
ican Type Culture Collection (Manassas, VA). The cells were
maintained in DMEM with 10% fetal bovine serum at 37 °C
with 5% carbon dioxide. Shh- and pcDNA-conditioned media
were prepared by transfecting 80% confluent 100-mm plates of
HEK 293 cells with 24 g of pRK5 full-length mouse Shh or
pcDNA3 using Lipofectamine (Life Technologies). The cells
were grown for 24 h; then they were washed with serum-star-
vation medium comprising DMEM and 0.5% FBS and further
cultured with the above medium for another 2 days. The
medium was harvested after centrifugation at 1000 rpm for 5
min. The supernatant was then sterile-filtered with a 0.22-m
syringe filter and kept at 80 °C. Prior to use, conditioned
medium was diluted 5 in the experimental solution. The
activity of Shh, both recombinant and in the conditioned
medium, was measured by a Gli-luciferase assay in NIH-3T3
cells, as previously described (25). Purmorphamine andKAAD-
cyclopamine were obtained from EMD Millipore (Billerica,
MA) and dissolved in DMSO.
Mouse cardiomyocyte electrophysiological recordings
The whole-cell patch clamp recordings were obtained from
myocytes isolated from the ventricles of adult (2–4months old)
WT, TTA, and GiCT/TTAmouse hearts. Action potential and
voltage-gated potassium currents recordings were conducted
using an Axopatch 200A amplifier (Molecular Devices, Union
City, CA), interfaced to a Dell microcomputer with a Digidata
1322A series analog/digital interface (Molecular Devices),
using pClamp 8 software (Molecular Devices). Whole-cell
patch-clamp experiments were conducted at room tempera-
ture (22–24 °C). Recording pipettes contained 135 mmol/liter
KCl, 1 mmol/liter MgCl2, 10 mmol/liter EGTA, 10 mmol/liter
HEPES, and 5 mmol/liter glucose (pH 7.2; 310 mOsm). The
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bath solution contained 136 mmol/liter NaCl, 4 mmol/liter
KCl, 1 mmol/liter CaCl2, 2 mmol/liter MgCl2, 5 mmol/liter
CoCl2, 10 mmol/liter HEPES, 0.04 mmol/liter tetrodotoxin,
and 10 mmol/liter D-glucose (pH 7.4; 300 mOsm). For current-
clamp experiments, the tetrodotoxin and CoCl2 were omitted
from the bath. Patch electrodes were fabricated and polished by
heating. We used pipettes with resistance of 2–4 M	. Whole-
cell membrane capacitances and series resistances were com-
pensated electronically prior to recording voltage-clamp cur-
rents. Voltage errors resulting from the uncompensated series
resistance were always 8mV and were not corrected. The
experimental data were sampled at 5 kHz; current and voltage
signals were low-pass–filtered at 1 kHz prior to digitization and
storage. For current-clamp experiments, a series of 1-ms-long
current steps from 10 to 250 pA in 20-pA increments were
delivered at 1-Hz frequency to cells in each group.
For action potential analysis, AP overshoot (peak depolariza-
tion) and restingmembrane potential were determined and the
difference between them yielded the spike height. AP duration
was measured as the time it took to cross the voltage at 25%
(APD25), 50% (APD50), 75% (APD75), and 90% (APD90) of the
spike height. Rheobase is themagnitude of a 1-ms current injec-
tion pulse sufficient to elicit an AP, and threshold was defined
as the voltage at which the dV/dt deviated from 0 mV ms1 as
determined from the phase-plane plot.
Depolarization-activated outward K (Kv) currents were
recorded in response to 4.5-s voltage steps to potentials
between 40 and  40 mV from a holding potential (HP) of
70 mV; voltage steps were presented in 10-mV increments
at 15-s intervals. Inwardly rectifying K currents, IK1, were
recorded in response to 350-ms voltage steps to test potentials
between 40 and 120 mV (in 10-mV increments) from the
same HP. Voltage-clamp data were compiled and analyzed
using Clampfit (Molecular Devices) and Origin 7.0 (OriginLab
Corp., Northampton, MA) software. Whole-cell membrane
capacitances (Cm) were acquired from Clampex (Molecular
Devices). Leak currents were always 10 pA and were not cor-
rected. Peak Kv currents at each test potential were defined as
the maximal outward K current recorded during the 4.5-s
voltage steps. The decay phases of the outward K currents
evoked during 4.5-s depolarizing voltage steps are described by
the sum of two exponentials using previously described meth-
ods: y(t)  A1exp(t/1)  A2exp(t/2)  B, where t is time,
1 and 2 are the decay time constants,A1 andA2 are the ampli-
tudes of the inactivating current components (Ito,fast or Ito,f and
IK,slow), and B is the amplitude of the noninactivating current
component, Iss (26). Fitting residuals and correlation coeffi-
cientswere determined to assess the quality of fits; only fits with
correlation coefficients 
0.980 were used in this study. In all
cells, IK1 densities were determined from the amplitudes of the
currents measured at the end of 350-ms hyperpolarizing volt-
age steps (90 to 120 mV) from a HP of 70 mV. Current
amplitudes in each cell were normalized to whole-cell mem-
brane capacitances (in the same cell), and current densities
(pA/pF) are reported.
The rapidly activating and rapidly inactivating Kv current,
Ito,f, was isolated by a two-step voltage protocol, using previ-
ously described procedures (27). Briefly, total whole-cell Kv
currents were first evoked in response to 4.5-s depolarizing
voltage steps to potentials between 40 and 40 mV (in
10-mV increments) from a holding potential of 70 mV. A
prepulse paradigm that included a brief (60ms) step to10mV
before the 4.5-s depolarizing voltage steps to potentials
between 40 and 40 mV (in 10-mV increments) was then
used. Off-line subtractions of the currents evoked with the pre-
pulse from the currents evoked without the prepulse were per-
formed to isolate Ito,f.
All electrophysiological recordings were conducted in the
whole-cell configuration. Pipette resistance was maintained
within the range of 1.5–1.8 M	. Recording pipettes were filled
with a solution containing 5 mmol/liter NaCl, 135 mmol/liter
CsF, 10 mmol/liter EGTA, 5 mmol/liter MgATP, and 5 mmol/
liter HEPES (pH 7.2) with CsOH. The cells were maintained in
a solution containing 5 mmol/liter NaCl, 132.5 mmol/liter
CsCl, 1 mmol/liter CaCl2, 1 mmol/liter MgCl2, 0.1 mmol/liter
CdCl2, 20 mmol/liter HEPES, and 11 mmol/liter glucose (pH
7.35) with CsOH.
Guinea pig cardiomyocyte action potential recording. Iso-
lated single ventricular myocytes were transferred to a static
bath recording chamber mounted on an Olympus CK40
invertedmicroscope. The cellswere allowed to settle in the bath
for 10–15 min before starting continuous perfusion (3–5
ml/min) with extracellular solution containing the following:
140mmol/liter NaCl, 4mmol/liter KCl, 1.8mmol/liter CaCl2, 1
mmol/liter MgCl2, 10 mmol/liter HEPES, 10 mmol/liter D-glu-
cose (pH adjusted to 7.4 with NaOH). Whole-cell patch-clamp
recordings were made in current clamp using patch pipettes of
4–7M	 resistance at room temperature (21–23 °C). To evalu-
ate the effect of purmorphamine on guinea pigmyocytes action
potential, the cells were preincubated with purmorphamine (5
mol/liter) for 1 h at 37 °C. Control measurements were taken
from the same untreated myocytes populations. The intracel-
lular solution consisted of 110 mmol/liter KCl, 10 mmol/liter
NaCl, 10mmol/liter EGTA, 1mmol/literMgCl2, 10mmol/liter
HEPES, 5 mmol/liter MgATP (pH 7.2, KOH). The signals were
acquired using aAxopatch 200B controlled byClampex 10 soft-
ware via a Digidata 1322A interface (Axon Instruments, Inc.,
Foster City, CA). Action potentials were evoked using current
injections with the smallest values used to reduce stimulus arti-
facts, and the cell was stimulated every 10 s with an averaged 10
APs used tomeasure action potential durations in both controls
and test conditions. Offline analysis was carried out using the
data analysis package Clampfit 10 (Axon Instruments), and the
data are expressed as means  S.E. Statistical analysis was per-
formed using unpaired Student’s t tests, where p  0.05 was
considered statistically significant.
Volume-conducted ECG
Adult mice were heparinized (0.5 unit/g intraperitoneally)
and then anesthetized with 2,2,2-tribromoethanol (Avertin;
425 mg/kg, intraperitoneal administration). Anesthesia was
confirmed by lack of the pinch reflex. The hearts were quickly
removed through a thoracotomy and rinsed in Tyrode’s solu-
tion (130 mmol/liter NaCl, 24 mmol/liter NaHCO, 1.2 mmol/
liter NaH2PO4, 1.0 mmol/liter MgCl2, 5.6 mmol/liter glucose,
4.0 mmol/liter KCl, and 1.8 mmol/liter CaCl2) and equilibrated
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with a 95% O2, 5% CO2 gas mixture. Hearts were then rapidly
cannulated, perfused in a retrograde fashion via an aortic can-
nula with 37 °C oxygenated Tyrode’s solution at the rate of 2–3
ml/min by using minipulse 3 peristaltic pump (Gilson Inc.,
Middleton, WI), and placed in a chamber. The solution in the
chamber was used as a volume conductor for recording ECGs.
ECGs were recorded with a Cyber Amp380 amplifier (Axon
Instruments) and digitized at 10 kHzwith aDigidata 1400A and
AxoScope 10.2 (Molecular Devices) after equilibration for 20
min as reported previously (28). In each record, theQT interval
was determined as the time from the start of ventricular activity
(the initiation of the QRS complex) to the time of minimum
voltage (29). QT intervals were corrected for heart rate using
the Bazzett’s formula QTc  QT/RR1/2, were RR is the interval
duration between two consecutive QRS complexes.
Immunofluorescence
Detection of Kv channel pore forming subunits (Kv4.2,
Kv4.3, Kv2.1, Kv1.5, Kv1.4, Kir2.1, andKir2.2)was performed as
described previously (5). Briefly, freshly isolatedmyocytes were
fixed in 4% paraformaldehyde for 20min and subsequently sus-
pended in PBS for immunostaining. The cells were collected
from 3–6 animals for each group. The cells were permeabilized
and blockedwith 0.2%TritonX-100 (Sigma) and 5%goat serum
(Invitrogen) in PBS and then incubated in primary antibody
overnight at 4 °C. The monoclonal anti-mouse Kv4.3 channels
(1:10, NeuroMab), anti-mouse Kv 4.2 (1:10, NeuroMab), anti-
rabbit Kv 1.5 (1:10, Alomone Labs), anti-mouse Kv 2.1 (1:10,
NeuroMab), anti-mouse Kv 1.4 (1:10, NeuroMab), anti-mouse
Kir 2.1(1:50, NeuroMab), and anti-mouse Kir2.2 (1:50, Neuro-
Mab) primary antibodies were used. After washes with 0.1%
Tween 20 in PBS, the cells were incubatedwith goat anti-mouse
Alexa Fluor 488 (Molecular Probes), goat anti-mouse Alexa
Fluor 555 (Molecular Probes), and secondary antibodies for 1 h
at room temperature and mounted using ProLong Gold anti-
fade reagents (Invitrogen). Stained slides were viewed with a
Zeiss LMS510Meta confocalmicroscope in Bioimaging Shared
Resource of the Sidney Kimmel Cancer Center (funded under
NCI, National Institutes of Health Grant 5 P30 CA-56036) at
Thomas Jefferson University.
To quantitatively assess Kv-channel distribution in myo-
cytes, eight Z-scan images were obtained at 0.25-m intervals
frommiddle of each cell, and a projection image was assembled
using National Institutes of Health Image 1.48v software. Data
from the lines at the outermost positions along the length of the
cell were used to get an average estimate of the fluorescence
distribution at or near the cell surface in each cell. For analysis
of fluorescence intensities, images were produced using identi-
cal acquisition settings. Pixel intensities at the cell periphery of
cardiomyocytes were determined using the histogram function
in NIH ImageJ software v1.48.
Western blotting
Western blots were performed on fractionated ventricular
membrane proteins prepared from adult WT and GiCT/TTA
mice hearts as previously described (28). Briefly, hearts were
homogenized on ice in a protease (Roche Applied Science) and
phosphatase inhibitors (Sigma) containing buffer consisting of
25 mmol/liter Tris-HCl (pH 7.5), 5 mmol/liter EDTA (pH 8),
and 5 mmol/liter EGTA (pH 8). The nuclei and debris were
pelleted by centrifugation at 1,000  g for 10 min. This proce-
dure was repeated, and the supernatants from both low-speed
spinswere pooled and centrifuged at 80,000 g for 30min. The
pellets were resuspended in the above solution and centrifuged
at 80,000 g for another 10 min. The final pellets were sonicated
and solubilized in protease and phosphatase inhibitors contain-
ing radioimmune precipitation assay buffer consisting of 50
mmol/liter Tris-HCl (pH 7.5), 5 mmol/liter EDTA (pH 8), 150
mmol/liter NaCl, 0.1% SDS, 1% NP40, 0.5% sodium deoxy-
cholate for 1 h. Insoluble material was centrifuged at 13,000
rpm for 10 min. Solubilized membranes were aliquoted and
stored frozen at80 °C until used. The protein content of each
of the solubilized membrane preparations was determined
using a protein assay kit (ThermoScientific). Proteinswere sep-
arated on a NuPAGE-Novex 4–12% bis-Tris gel (Invitrogen)
and transferred onto nitrocellulose membranes. The mem-
branes were then blocked and incubated overnight at 4 °C
with primary antibodies. The blots were then incubated with
secondary antibody conjugated to horseradish peroxidase
(1:5000), and visualized using SuperSignal West Pico chemilu-
minescent substrate (Thermo Scientific). For normalization of
signals, blotting was performed with an anti--actin mAb, fol-
lowed by incubation with an IRDye 680- or IRDye 800CW-
conjugated secondary antibody (Li-Cor). Themembranes were
imaged with the Odyssey IR imaging system (Li-Cor), and
quantitative densitometric analysis was performed by applying
Odyssey version 1.2 IR imaging software.
Statistics
The results are expressed as means  S.E. Statistical signifi-
cance was examined with Student’s t test, one-way ANOVA, or
chi-squared test. p  0.05 was considered significant.
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